Open AccessResponse of an ERBB2-Mutated Inflammatory Breast Carcinoma to Human Epidermal Growth Factor Receptor 2–Targeted Therapy
Author(s) -
Siraj M. Ali,
R. Katherine Alpaugh,
Sean R. Downing,
Philip J. Stephens,
Jian Yu,
Hong Wu,
Jamie Buell,
Vincent A. Miller,
Doron Lipson,
Gary A. Palmer,
Jeffrey S. Ross,
Massimo Cristofanilli
Publication year - 2014
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2013.49.0599
Subject(s) - medicine , human epidermal growth factor receptor 2 , epidermal growth factor receptor , oncology , targeted therapy , breast carcinoma , cancer research , epidermal growth factor , breast cancer , receptor , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom